Trifocal Intraocular Lens (IOL) Aberrometry Outcomes

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04196569
Collaborator
Alcon Research (Industry)
25
1
35.6
0.7

Study Details

Study Description

Brief Summary

The goal of this study is to evaluate subject outcomes and spectacle independence with intraoperative aberrometry and trifocal IOL implantation.

Condition or Disease Intervention/Treatment Phase
  • Device: Alcon Trifocal and Trifocal Toric Intraocular Lenses

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Spectacle Independence After Implantation of Trifocal and Trifocal Toric Intraocular Lenses Using Intraoperative Aberrometry: A Prospective Analysis
Actual Study Start Date :
Dec 12, 2019
Anticipated Primary Completion Date :
Oct 30, 2022
Anticipated Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
trifocal intraocular lens

Device: Alcon Trifocal and Trifocal Toric Intraocular Lenses
Panoptix Model #TFAT00 for the UV Absorbing Trifocal IOL. Torics: TFAT30, TFAT40, TFAT50, TFAT60

Outcome Measures

Primary Outcome Measures

  1. Percentage of spectacle independence (overall) [1 month post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

  2. Percentage spectacle independence (overall) [3 months post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

Secondary Outcome Measures

  1. Spectacle independence for distance, intermediate and near [1 month post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

  2. Spectacle independence for distance, intermediate and near [3 months post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

  3. Spectacle independence subgroup analysis for subjects within 0.50 D spherical equivalent (SE) [1 month post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

  4. Spectacle independence subgroup analysis for subjects within 0.50 D spherical equivalent (SE) [3 months post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

  5. Binocular, uncorrected distance visual acuity for patients within 0.50 D of intended target [3 months post-cataract surgery]

    This will be measured by visual acuity

  6. Subject satisfaction [3 months post-cataract surgery]

    This will be assessed by a Visual Quality Questionnaire, an 18 question multiple choice questionnaire to assess vision-related functioning. Grading scale: 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. Mean value(s) will be analyzed.

  7. Uncorrected binocular and monocular visual acuity at all distances [3 months post-cataract surgery]

    This will be measured by visual acuity

  8. Distribution of residual refractive error [3 months post-cataract surgery]

    This will be measured by refractive error

  9. Contrast sensitivity (binocular) [1 month post-cataract surgery]

    This will be measured by contrast sensitivity testing

  10. Contrast sensitivity (binocular) [3 months post-cataract surgery]

    This will be measured by contrast sensitivity testing

  11. Percentage of subjects with <=0.50 D of refractive cylinder [1 month post-cataract surgery]

    This will be measured by refractive error

  12. Percentage of subjects with <=0.50 D of refractive cylinder [3 months post-cataract surgery]

    This will be measured by refractive error

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Able to consent to study and cataract surgery

  • Visually significant cataract

  • Potential post-operative visual acuity of 20/25 or better

  • Age 18 years or older

Exclusion Criteria:
  • Ocular pathology contraindicated for trifocal IOLs including but not limited to diabetic retinopathy, age-related macular degeneration or other macular pathology, cornea guttata, corneal scarring, corneal ectasia, glaucoma with visual field loss

  • Irregular astigmatism

  • Prior corneal refractive surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Weill Cornell Medicine New York New York United States 10021

Sponsors and Collaborators

  • Weill Medical College of Cornell University
  • Alcon Research

Investigators

  • Principal Investigator: Ashley Brissette, MD, Weill Medical College of Cornell University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT04196569
Other Study ID Numbers:
  • 19-05020251
First Posted:
Dec 12, 2019
Last Update Posted:
Mar 11, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Weill Medical College of Cornell University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 11, 2022